Rao spoke with Cardiovascular Business at ACC.23 to detail some of SCAI's biggest accomplishments from the last year. 

SCAI President Sunil Rao, MD, spoke with us about some of the key interventional cardiology studies presented at ACC.23 in New Orleans. 

Cardiology has the second largest number of FDA-cleared AI algorithms, and many of them are for cardiac ultrasound. Echocardiography expert Patricia A. Pellikka, MD, discusses this trend and how AI is helping improve echo.

Atul Verma, MD, director of cardiology at McGill University Health Centre in Montreal, explained why the late-breaking PULSED-AF trial data on Medtronic’s pulsed-field ablation technology is so important for cardiologists. 

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

Cathie Biga, vice president of the American College of Cardiology, spoke to Cardiovascular Business at ACC.23 about challenges in the world of cardiology reimbursements. "As that healthcare dollar goes up, it is not going to the physicians," she said.

Steven Nissen, MD, spoke with Cardiovascular Business at ACC.23 about the late-breaking CLEAR Outcomes trial.

Paul Sorajja, MD, discusses the late-breaking TRILUMINATE pivotal trial at ACC.23 and how tricuspid TEER performed against the current standard of care using medical therapy.